ArticleJournal of bone oncology2026
Dissociated skeletal response to first-line immunotherapy in synchronous bone metastatic non-small cell lung cancer patients: Clinical profiles and survival benefit of denosumab adjunction.
E Massy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.